+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Glycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male rats



Glycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male rats



Journal of Psychiatry and Neuroscience 38(5): 306-316



Glutamate N-methyl-D-aspartate (NMDA) receptor antagonists exert fast-acting antidepressant effects, providing a promising way to develop a new classification of antidepressant that targets the glutamatergic system. In the present study, we examined the potential antidepressant action of 7-chlorokynurenic acid (7-CTKA), a glycine recognition site NMDA receptor antagonist, in a series of behavioural models of depression and determined the molecular mechanisms that underlie the behavioural actions of 7-CTKA. We administered the forced swim test, novelty-suppressed feeding test, learned helplessness paradigm and chronic mild stress (CMS) paradigm in male rats to evaluate the possible rapid antidepressant-like actions of 7-CTKA. In addition, we assessed phospho-glycogen synthase kinase-3β (p-GSK3β) level, mammalian target of rapamycin (mTOR) function, and postsynaptic protein expression in the medial prefrontal cortex (mPFC) and hippocampus. Acute 7-CTKA administration produced rapid antidepressant-like actions in several behavioural tests. It increased p-GSK3β, enhanced mTOR function and increased postsynaptic protein levels in the mPFC. Activation of GSK3β by LY294002 completely blocked the antidepressant-like effects of 7-CTKA. Moreover, 7-CTKA did not produce rewarding properties or abuse potential. It is possible that 7-CTKA modulates glutamatergic transmission, thereby causing enduring alterations of GSK3β and mTOR signalling, although we did not provide direct evidence to support this possibility. Thus, the therapeutic involvement of synaptic adaptions engaged by 7-CTKA requires further study. Our findings demonstrate that acute 7-CTKA administration produced rapid antidepressant-like effects, indicating that the behavioural response to 7-CTKA is mediated by GSK3β and mTOR signalling function in the mPFC.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053428521

Download citation: RISBibTeXText

PMID: 23611177

DOI: 10.1503/jpn.120228


Related references

Effects of L-701,324, a high-affinity antagonist at the N-methyl-D-aspartate (NMDA) receptor glycine site on the rat electroencephalogram. Naunyn Schmiedeberg's Archives of Pharmacology 355(6): 779-786, 1997

Effects of L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor, on the electroencephalogram and NMDA-evoked responses in the rat striatum. British Journal of Pharmacology 117(PROC Suppl. ): 26P, 1996

The discriminative stimulus effects of N-methyl-D-aspartate glycine-site ligands in NMDA antagonist-trained rats. Psychopharmacology 203(2): 441-451, 2009

Delayed treatment with 5-nitro-6,7-dichloro-1,4-dihydro-2,3-quinoxalinedione, a glycine site N-methyl-D-aspartate antagonist, protects against permanent middle cerebral artery occlusion in male rats. Neuroscience Letters 347(3): 147-150, 2003

Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine produces antidepressant effects in rats: role of brain-derived neurotrophic factor. Neuroscience 223: 219-224, 2012

Differential modulation of the associated glycine recognition site by competitive n methyl d aspartate receptor antagonist. Molecular Pharmacology 37(6): 780-784, 1990

In vitro pharmacological properties of the N-methyl-D-aspartate receptor glycine site antagonist, SM-18400. Society for Neuroscience Abstracts 24(1-2): 574, 1998

Characterization of the binding of [3H]L-689,560, an antagonist for the glycine site on the N-methyl-D-aspartate receptor, to rat brain membranes. Molecular Pharmacology 41(5): 923-930, 1992

The excitatory amino acid n methyl d aspartate produces discriminative stimuli antagonized by a selective n methyl d aspartate receptor antagonist. Psychopharmacology 89(4): S44, 1986

Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complex. British Journal Of Pharmacology. 117(5): 931-937, 1996

7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proceedings of the National Academy of Sciences of the United States of America 85(17): 6547-6550, 1988

Reevaluation of ACEA 1021 as an antagonist at the strychnine-insensitive glycine site of the N-methyl-D-aspartate receptor. Neuropharmacology 37(6): 729-737, 1998

Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site. Molecular Pharmacology 38(4): 554-561, 1990

Autoradiographical analysis of the binding of tritiated L-689560, an antagonist of the glycine site on the N-methyl-D-aspartate receptor, to rat brain. British Journal of Pharmacology 107(PROC Suppl. DEC ): 342P, 1992

Safety and tolerability of GV150526 (a glycine site antagonist at the N-methyl-D-aspartate receptor) in patients with acute stroke. Stroke 30(5): 986-992, 1999